Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China’s MOH To Explore Further Health Care Reform

This article was originally published in PharmAsia News

Executive Summary

At a recent Ministry of Health internal seminar, deputy minister Gao Qiang expressed that the ministry must free up ideas and explore the following issues: (1) separation between administration and operation of health care institutions with hospitals assuming responsibility of operations, while the government evaluates their performance; (2) separate the revenue of health care services and medicine sales by severing the profit links between them; (3) strictly distinguish between profit and non-profit health care institutions based on their classification criteria, charging standard, economic policies and financial management systems; and (4) resolve the problem of medical education and a research system where study is divorced from practice. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067479

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel